January 21 (SeeNews) - A Swiss-based investment fund has filed the most attractive offer for the acquisition of the assets of Serbian insolvent pharmaceutical company Jugoremedija, news agency Tanjug reported.
It is up to the board of creditors now to decide whether Jugoremedija's assets will be sold or not, Tanjug quoted on Monday board president Vladimir Savic as saying.
You can subscribe to our M&A newsletter here
Jugoremedija's assets, including a factory in Zrenjanin, were offered for sale through direct talks, which began earlier this month, insolvency administrator Radovan Savic said last week.
"Of the three bidders, none is a pharmaceutical company, a drug maker or a drug dealer," Tanjug quoted the chairman of Jugoremedija, Vladimir Pecikoza, as saying.
The board of creditors will come up with a decision in the next few days, as the biggest creditors from Turkey have asked to be given several days for consultations, Pecikoza said.
Jugoremedija entered into bankruptcy proceedings in 2012. The company was declared bankrupt in 2016 and the Serbian government has held a total of seven unsuccessful tenders for its sale since then.
The most important assets of the company are the industrial complex in Zrenjanin, which comprises several facilities, as well as 24 trademarks, 28 motor vehicles, inventory and supplies.